Theorem Clinical Research Names Joseph Sgherza to Head Infectious Disease Franchise


(King of Prussia, PA; Sept. 26, 2013) — A veteran of 24 years in the pharmaceutical, biotech and CRO industries, has been named vice president of biopharmaceutical development for the of .

“Joe is truly a leader in this area,” said Theorem President and CEO John Potthoff. “He has developed and managed numerous global clinical programs in infectious diseases in all phases, from launch to patent expiration, and led clinical development teams to eight successful NDAs in infectious disease, hepatology and oncology.”

Prior to joining Theorem, Sgherza was portfolio director for PAREXEL International Corporation, where he was responsible for the operational execution of pharmaceutical trials in infectious disease, biologics and oncology. As executive vice president for SPRI Clinical Trials, Sgherza successfully hired, trained and developed 78 team members in Ukraine and other areas in Eastern Europe for a new clinical research operations division, while simultaneously conducting 15 clinical trial programs there over three years. He also held posts as of clinical operations for Neeman Medical International, as site management operations director for Duke Clinical Research and as senior manager of the worldwide anti-infective medical team for Pfizer.

“We are building our therapeutic franchises with the best people we can find in each field,” Potthoff said. “Joe Sgherza is a perfect fit for Theorem.”

About Theorem Clinical Research
Theorem Clinical Research Inc. is a leading midsized provider of comprehensive clinical research and development services with offices in more than 30 countries and a customer base comprised of some of the world’s top pharmaceutical, biotech and medical device companies. As a forerunner in medical device and drug-device combination trials with notable capabilities in pharmaceuticals and biologics, Theorem offers deep expertise in a…Read more

Pharmalive – The Pulse of the Pharmaceutical Industry

Share This Post

Related Articles

Leave a Reply

© 2019 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS